Thomas Pleli
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Hepatology top 5%
Papers in ⓘ
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- MicroRNA in disease regulation 6
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Albrecht Piiper (22 shared papers)Stefan Zeuzem (19 shared papers)Oliver Waidmann (17 shared papers)Bernd Kronenberger (13 shared papers)Verena Köberle (10 shared papers)Christian Schmithals (11 shared papers)Jörg Trojan (3 shared papers)Jan Peveling‐Oberhag (3 shared papers)
In The Last Decade
Thomas Pleli
23 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 448
- Hepatology 167
- Molecular Biology 599
- Oncology 233
- Immunology 152
Countries citing papers authored by Thomas Pleli
This map shows the geographic impact of Thomas Pleli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pleli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pleli more than expected).
Fields of papers citing papers by Thomas Pleli
This network shows the impact of papers produced by Thomas Pleli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pleli. The network helps show where Thomas Pleli may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Pleli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 171 | |
| 2 | 2013 | 158 | |
| 3 | 2013 | 154 | |
| 4 | 2011 | 109 | |
| 5 | 2014 | 57 | |
| 6 | 2015 | 54 | |
| 7 | 2012 | 44 | |
| 8 | 2013 | 33 | |
| 9 | 2017 | 31 | |
| 10 | 2014 | 31 | |
| 11 | 2014 | 30 | |
| 12 | 2015 | 28 | |
| 13 | 2014 | 27 | |
| 14 | 2018 | 26 | |
| 15 | 2018 | 23 | |
| 16 | 2017 | 21 | |
| 17 | 2019 | 20 | |
| 18 | 2015 | 15 | |
| 19 | 2009 | 11 | |
| 20 | 2020 | 10 |
About Thomas Pleli
Thomas Pleli is a scholar working on Hepatology, Cancer Research, Physiology, Biological Psychiatry and Pharmacology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Hepatitis B Virus Studies (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Extracellular vesicles in disease (3 papers), RNA Interference and Gene Delivery (3 papers) and Lanthanide and Transition Metal Complexes (2 papers). The work is most often cited by research in Cancer Research (448 citations), Hepatology (167 citations), Molecular Biology (599 citations), Oncology (233 citations) and Immunology (152 citations). Thomas Pleli has collaborated with scholars based in Germany, Egypt and Spain. Frequent co-authors include Albrecht Piiper, Stefan Zeuzem, Oliver Waidmann, Bernd Kronenberger, Verena Köberle, Christian Schmithals, Jörg Trojan, Jan Peveling‐Oberhag, Harald Farnik and Fabian Finkelmeier. Their work appears in journals such as PLoS ONE, Scientific Reports, European Journal of Cancer, Journal of Viral Hepatitis and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.